U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508462) titled 'A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects' on March 24.

Brief Summary: This study is a single-dose, randomized, open-label, three-sequence, three-period crossover clinical trial to evaluate the effect of high-fat and low-fat meals on the pharmacokinetics of ammoxetine hydrochloride enteric-coated tablets in healthy subjects.

Study Start Date: May 30, 2024

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Ammoxetine hydrochloride enteric-coated tablets

Single-dose of 60 mg of ammoxetine hydrochlorid...